Back to Authors

Dave, Hema

0000-0001-5530-0201

A5086969450 | I1290900354

Mayo Clinic

Tufts Medical Center

Citations 2

Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma

New England Journal of Medicine | November 2, 2022 | Volume: 387 | Issue: 18 | Pages: 1649-1660

10.1056/nejmoa2206660 | PMID 36322844

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma

HemaSphere | October 10, 2022 | Volume: 6 | Issue: No issue available | Pages: 40-40

10.1097/01.hs9.0000890916.12776.84